The Identification, Review and Synthesis of Health State Utility Values from the Literature

Brazier J, Ara R, Chevrou-Severac H. W3: Utilities in economic evaluation: using best practices where international guidelines provide insufficient detail. www.ispor.org/Event/ProgramList/2016Vienna?type=Workshop . Accessed 13 April 2017.

Peasgood T, Herrmann K, Kanis JA, Brazier JE. An updated systematic review of health state utility values for osteoporosis related conditions. Osteoporos Int. 2009;20(6):853.

Kanis JA, Stevenson M, McCloskey EV, Davis S, Lloyd-Jones M. Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess. 2007;11(7):1–231.

Papaioannou D, Brazier JE, Paisley S. NICE DSU Technical Support Document 9: the identification, review and synthesis of health state utility values from the literature. National Health Service, 2010. http://www.nicedsu.org.uk .

Papaioannou D, Brazier J, Paisley S. Systematic searching and selection of health state utility values from the literature. Value Health. 2013;16(4):686–95.

Rowen D, Azzabi Zouraq I, Chevrou-Severac H, van Hout B. International regulations and recommendations. Current issue Pharmacoeconomics.

Guide to the methods of technology appraisal 2013 NICE. www.nice.org.uk/process/pmg9/chapter/foreword . Accessed April 2017.

Brazier J, Ara R, Rowen D, Chevrou-Severac H. A review of generic preference-based measures for use in cost-effectiveness models. PharmacoEconomics. 2017. doi: 10.1007/s40273-017-0545-x .

Rowen D, Brazier J, Ara R, Azzabi Zouraq I. The role of condition-specific preference-based measures in health technology assessment. PharmacoEconomics. 2017. doi: 10.1007/s40273-017-0546-9 .

Ara R, Rowen D, Mukuria C. The use of mapping to estimate health state utility values. PharmacoEconomics. 2017. doi: 10.1007/s40273-017-0548-7 .

Critical Appraisal Skills Programme CASP (systematic review checklist). 2017. http://www.casp-uk.net/ .

Arber M, Garcia S, Veale T, Edwards M, Shaw A, Glanville J. Performance of search filters to identify health state utility studies. 2016. ISPOR 19th Annual European Congress. Vienna.

Paisley S, Booth A, Mensinkai S. Health-related quality of life studies. Etext on Health Technology Assessment (HTA) information resources. Bethesda, MD: US National Library of Medicine (NLM), National Information Center on Health Services Research and Healthcare Technology (NICHSR), 2005.

Wolowacz SE, Briggs A, Belozeroff V, Clarke P, Doward L, Goeree R, Lloyd A, Norman R. Estimating health-state utility for economic models in clinical studies: an ISPOR Good Research Practices Task Force Report. Value Health. 2016;19(6):704–19.

Doth AH, Hansson PT, Jensen MP, Taylor RS. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain. 2010;149(2):338–44.

Higgins J, Thompson S. Controlling the risk of spurious findings from meta-regression. Stat Med. 2004;23:1663–82.

Borenstein M, Hedges LV, Higgins JP, Rothstein HR. Introduction to meta-analysis. New York: Wiley; 2011.

Peasgood T, Brazier J. Is meta-analysis for utility values appropriate given the potential impact different elicitation methods have on values? Pharmacoeconomics. 2015;33(11):1101–5.